36 results
8-K
EX-10.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
17 Oct 23
Entry into a Material Definitive Agreement
7:24pm
to the minority interest in such Subsidiary) and (f) any gains or losses (less all fees and expenses chargeable thereto) attributable to any sales
424B3
3d99yrd1fvp6xw2b6
16 Mar 07
Prospectus supplement
12:00am
DEFM14A
4sqm ha2fw4jbzt8hhg9
24 Jan 07
Proxy related to merger
12:00am
PRER14A
svebtnicgv11 ph2m
14 Dec 06
Preliminary revised proxy
12:00am
PREM14A
5t850j8d7tfbl
6 Nov 06
Preliminary proxy related to merger
12:00am
POS AM
937bm7bx6imp
12 Apr 06
Prospectus update (post-effective amendment)
12:00am
PREN14A
f9orkc7vsudd0s fr
9 Nov 05
Preliminary proxy statement filed by non-management
12:00am